Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6442-6446

  Cui, Hengmi ^a   Onyango, Patrick ^a   Brandenburg, Sheri ^a   Wu, Yiqian ^a   Hsieh, Chih Lin ^b   Feinberg, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; SOMATOMEDIN B;

ALLELE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; ENHANCER REGION; EXON; GENE; GENE LOSS; GENETIC LINKAGE; GENOME IMPRINTING; H19 GENE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE;

COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; POLYMORPHISM, GENETIC; RNA, UNTRANSLATED; TUMOR CELLS, CULTURED;

EID: 0037112364     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Feinberg, A. P., and Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (Lond.), 301: 89-92, 1983
2. Feinberg, A. P., Gehrke, C. W., Kuo, K. C., and Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res., 48: 1159-1161, 1988
3. Baylin, S. B., Hoppener, J. W., de Bustros, A., Steenbergh, P. H., Lips, C. J., and Nelkin, B. D. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res., 46: 2917-2922, 1986
4. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995
5. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., and Feinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993
6. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., and Reeve, A. E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’ tumour. Nature (Lond.), 362: 749-751, 1993
7. Pedersen, I. S., Dervan, P. A., Broderick, D., Harrison, M., Miller, N., Delany, E., O’Shea, D., Costello, P., McGoldrick, A., Keating, G., Tobin, B., Gorey, T., and McCann, A. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res., 59: 5449-5451, 1999
8. Lee, M. P., DeBaun, M. R., Mitsuya, K., Galonek, H. L., Brandenburg, S., Oshimura, M., and Feinberg, A. P. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KvLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl. Acad. Sci. USA, 96: 5203-5208, 1999
9. Kohda, M., Hoshiya, H., Katoh, M., Tanaka, I., Masuda, R., Takemura, T., Fujiwara, M., and Oshimura, M. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma. Mol. Carcinog., 31: 184-191, 2001
10. Cai, Y. C., Yang, G. Y., Nie, Y., Wang, L. D., Zhao, X., Song, Y. L., Seril, D. N., Liao, J., Xing, E. P., and Yang, C. S. Molecular alterations of p73 in human esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis (Lond.), 21: 683-689, 2000
11. Tanaka, K., Shiota, G., Meguro, M., Mitsuya, K., Oshimura, M., and Kawasaki, H. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer. Oncology, 60: 268-273, 2001
12. Ravenel, J. D., Broman, K. W., Perlman, E. J., Niemitz, E. L., Jayawardena, T. M., Bell, D. W., Haber, D. A., Uejima, H., and Feinberg, A. P. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl. Cancer Inst., 93: 1698-1703, 2001
13. Zhan, S., Shapiro, D. N., and Helman, L. J. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin. Investig., 94: 445-448, 1994
14. Rainier, S., Dobry, C. J., and Feinberg, A. P. Loss of imprinting in hepatoblastoma. Cancer Res., 55: 1836-1838, 1995
15. Kim, H. T., Choi, B. H., Niikawa, N., Lee, T. S., and Chang, S. I. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am. J. Med. Genet., 80: 391-395, 1998
16. Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., and Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med., 4: 1276-280, 1998
17. Kondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Takahashi, T., and Takahashi, T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene, 10: 1193-1198, 1995
18. Elkin, M., Shevelev, A., Schulze, E., Tykocinsky, M., Cooper, M., Ariel, I., Pode, D., Kopf, E., de Groot, N., and Hochberg, A. The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Lett., 374: 57-61, 1995
19. Randhawa, G. S., Cui, H., Barletta, J. A., Strichman-Almashanu, L. Z., Talpaz, M., Kantarjian, H., Deisseroth, A. B., Champlin, R. C., and Feinberg, A. P. Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood, 91: 3144-3147, 1998
20. Steenman, M. J., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms’ tumour. Nat. Genet., 7: 433-439. 1994
21. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., Kraus, W., Gerald, W., and Tycko, B. Epigenetic lesions at the H19 locus in Wilms’ tumour patients. Nat. Genet., 7: 440-447, 1994
22. Leighton, P. A., Ingram, R. S., Eggenschwiler, J., Efstratiadis, A., and Tilghman, S. M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature (Lond.), 375: 34-39, 1995
23. Ohlsson, R., Renkawitz, R., and Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet., 17: 520-527, 2001
24. Reik, W., and Murrell, A. Genomic imprinting, silence across the border. Nature (Lond.), 405: 408-409, 2000
25. Hark, A. T., Schoenherr, C. J., Katz, D. J., Ingram, R. S., Levorse, J. M., and Tilghman, S. M. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature (Lond.), 405: 486-489, 2000
26. Bell, A. C., and Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature (Lond.), 405: 482-485, 2000
27. Cui, H., Niemitz, E. L., Ravenel, J. D., Onyango, P., Brandenburg, S. A., Lobanenkov, V. V., and Feinberg, A. P. Loss of imprinting of insulin-like growth factor-II in Wilms’ tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res., 61: 4947-4950, 2001
28. Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E., Cui, H., Feinberg. A. P., Lengauer, C., Kinzler, K. W., Baylin, S. B., and Vogelstein, B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (Lond.), 416: 552-556, 2002
29. Okano, M., Bell, D. W., Haber, D. A., and Li, E. DNA methyttransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99: 247-257, 1999
30. Hata, K., Okano, M., Lei, H., and Li, E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development (Camb.), 129: 1983-1993, 2002
31. Hsieh, C. L. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol., 14: 5487-5494, 1994
32. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., and Calos, M. P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol., 7: 379-387, 1987
33. Uejima, H., Lee, M. P., Cui, H., and Feinberg, A. P. Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat. Genet., 25: 375-376, 2000
34. Sullivan, M. J., Taniguchi, T., Jhee, A., Kerr, N., and Reeve, A. E. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene, 18: 7527-7534, 1999
35. Nakagawa, H., Chadwick, R. B., Peltomaki, P., Plass, C., Nakamura, Y., and de La Chapelle, A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. USA, 98: 591-596, 2001
36. Strichman-Almashanu, L. Z., Lee, R. S., Onyango, P. O., Perlman, E., Folke, F., Frieman, M. B., and Feinberg, A. P. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res., 12: 543-554, 2002
37. Takai, D., Gonzales, F. A., Tsai, Y. C., Thayer, M. J., and Jones, P. A. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet., 10: 2619-2626, 2001
38. Hu, J. F., Vu, T. H., and Hoffman, A. R. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J. Biol. Chem., 272: 20715-20720, 1997
39. Constancia, M., Dean, W., Lopes, S., Moore, T., Kelsey, G., and Reik, W. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat. Genet., 26: 203-206, 2000